Adma Biologics | ADMA - Selling And Administration Expenses


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Adma Biologics

Adma Biologics reported $32.58M in Selling and Administration Expenses for its fiscal quarter ending in March of 2023.


Selling And Administration Expenses Change
Adamis Pharmaceuticals ADMP:US USD 4.78M 1.63M
Adma Biologics ADMA:US USD 32.58M 13.6M
Agile Therapeutics AGRX:US USD 15.51M 6.64M
Alnylam Pharmaceuticals ALNY:US USD 183.66M 26.68M
BioCryst Pharmaceuticals BCRX:US USD 47.87M 2.29M
Dynavax Technologies DVAX:US USD 36.54M 6.16M
Minerva Neurosciences NERV:US USD 2.69M 815.12K
Novavax NVAX:US USD 112.53M 49.13M
Takeda 4502:JP JPY 254.8B 7.5B